Maeve O’Reilly - Concepedia

Author

Maeve O’Reilly

Also Known As

M O'Reilly, M OReilly, M O’Reilly, M. A. O'Reilly, M. O'Reilly, M. O’Reilly, M.A. O'Reilly, MD Eileen M. O'Reilly,, Maeve A O'Reilly, Maeve A. O'Reilly

120

Publications

2.8K

Citations

H-Index

Concepts

All Affiliations

University College London University College London Hospitals NHS Foundation Trust King's College Hospital CRUK Lung Cancer Centre of Excellence Manchester Royal Infirmary

About

Maeve O’Reilly is an author at University College London specializing in immunotherapy, autoimmunity, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	109
2	Immunology	3	3	109
3	Biomedical Engineering	1	1	17
4	Cellular Therapies	1	1	17
5	Clinical Immunology	1	1	24

Maeve O’Reilly

Publications

2.4K

Citations

H-Index

Page 1

	Year	Citations
Exercise and associated dietary extremes impact on gut microbial diversity Siobhan F. Clarke, Eileen F. Murphy, Órla O’Sullivan, Gut	2014	1.4K
Durable Responses and Low Toxicity After Fast Off-Rate CD19 Chimeric Antigen Receptor-T Therapy in Adults With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia Claire Roddie, Juliana Dias, Maeve O’Reilly, Journal of Clinical Oncology	2021	133
Effective bridging therapy can improve CD19 CAR-T outcomes while maintaining safety in patients with large B-cell lymphoma Claire Roddie, Lorna Neill, Wendy Osborne, Blood Advances	2023	133
Recent Bendamustine Treatment Before Apheresis Has a Negative Impact on Outcomes in Patients With Large B-Cell Lymphoma Receiving Chimeric Antigen Receptor T-Cell Therapy Gloria Iacoboni, Vı́ctor Navarro, Ana África Martín‐López, Journal of Clinical Oncology	2023	108
A national service for delivering <scp>CD19 CAR‐T</scp>in large B‐cell lymphoma – The <scp>UK</scp> real‐world experience Andrea Kühnl, Claire Roddie, Amy A. Kirkwood, British Journal of Haematology	2022	101
Early FDG-PET response predicts CAR-T failure in large B-cell lymphoma Andrea Kühnl, Claire Roddie, Amy A. Kirkwood, Blood Advances Lymphoid NeoplasiaMedicineMalignant Blood DisorderImmunologyPathology	2021	68
Dual targeting of CD19 and CD22 with Bicistronic CAR-T cells in Patients with Relapsed/Refractory Large B Cell Lymphoma Claire Roddie, Lazaros J. Lekakis, Maria A. V. Marzolini, Blood	2023	68
Hajdu-Cheney syndrome. Maeve O’Reilly, D G Shaw Annals of the Rheumatic Diseases	1994	63
CD34<b>+</b>-selected stem cell boost can safely improve cytopenias following CAR T-cell therapy Khushnuma Mullanfiroze, Arina Lazareva, Jan Chu, Blood Advances	2022	45
Real-World Data of High-Grade Lymphoma Patients Treated with CD19 CAR-T in England Andrea Kühnl, Claire Roddie, Núria Martínez‐Cibrián, Blood	2019	33

Page 1